Organizational Chart – Pancreatology and Digestive Oncology Department
The Team
![]() |
Prof. Vinciane Rebours Head of Department Publications |
| Dr. Anne-Laure Vedie
Senior Hospital Practitioner |
|
| Dr. Grégoire Salin
Associate Practitioner |
|
| Dr. Ali Allouche
Associate Practitioner |
|
| Dr. Caroline Lacombe
Shared Clinical Assistant |
|
| Dr. Justine Tremblais
Hospital Assistant |
|
| Dr. Johanna Pokossy
Assistant Clinic Head |
|
| Dr. Clémence Descouvières
Assistant Clinic Head |
|
![]() |
Dr. Olivia Hentic
Senior Hospital Practitioner Publications |
![]() |
Dr. Frédérique Maire
Senior Hospital Practitioner Publications |
![]() |
Dr. Nelly Muller
Senior Hospital Practitioner |
![]() |
Dr. Lucie Laurent
Senior Hospital Practitioner |
![]() |
Pr. Louis de Mestier University Professor Publications |
GENERAL OVERVIEW OF THE DEPARTMENT — WHO ARE WE? WHAT DISEASES DO WE TREAT?
The Pancreatology and Digestive Oncology Department at Beaujon Hospital is the only department in France entirely dedicated to diseases of the pancreas.
We provide care for all types of pancreatic diseases, including:
The most common:
-
Pancreatic cancer, including rare familial forms
-
Acute pancreatitis
-
Chronic pancreatitis
As well as rare diseases:
-
Digestive and pancreatic neuroendocrine tumors (NETs)
-
Pancreatic cystic tumors (intraductal tumors, cystadenomas, solid pseudopapillary tumors, etc.)
-
Autoimmune pancreatitis
-
Hereditary pancreatitis
-
Metabolic pancreatitis
-
Post-traumatic pancreatitis
-
Pancreatic malformations
Accreditations and Expertise
-
The department has been designated a National Reference Center for Rare Pancreatic Diseases (PaRaDis) for the past four years.
-
It has also been recognized as a European Center of Excellence for the treatment of neuroendocrine tumors since 2009.
Collaborative and Multidisciplinary Care
We collaborate daily with internationally renowned departments including:
-
Pancreatic Surgery
-
Endoscopy
-
Radiology
-
Nuclear Medicine
-
Pathology (Anatomopathology)
-
Intensive Care
We offer rapid access (within one week) for urgent pancreatic cancer cases, particularly within the framework of the HOPE multidisciplinary consultation (Hepatic Or Pancreatic Evaluation), where our specialized expertise is requested.







